ARCHIVES

Lederle Scientists Report Powerful New Anticancer Agent

This article is from The Cancer Letter archive.

Vol. 13 No. 31 | July 31, 1987

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

In Brief: Abeloff Directs John Hopkins Oncology Center; Claudia Baquet Named Deputy Secretary In HHS

September 25, 1992

NCI Extends PRI’s Fredrick Contract Six Months

September 23, 1994

NCI Clinical Trials Enrollment Drops to 17,500

February 21, 2014

OMB Budget Revision Would Cut Centers $20 Million, Slash Clinical Education, Training, Contracts Funds

April 22, 1983

Legislation Would Create Medicare Service For Comprehensive Cancer Care planning.

May 26, 2006